Showing results (81-90 of 294) with videos related to
Sort By:
Pageof 30
Molecular Cancer Research : MCR|May 14, 2009
Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanismSonyo Shin, Takayuki Asano, Yixin Yao, et al.Frontiers in Pharmacology|May 16, 2022
An Automated Quantification Tool for Angiogenic Sprouting From Endothelial SpheroidsPavitra Kannan, Martin Schain, David P LaneNature Reviews. Drug Discovery|December 2, 2008
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathwaysAnwesha Dey, Vinay Tergaonkar, David P LaneScientific Reports|January 6, 2025
Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic toolsDiana Spiegelberg, Le-Ann Hwang, Khian Hong Pua, et al.Seminars in Cancer Biology|March 3, 2010
Modulating the p53 pathwayAnwesha Dey, David P Lane, Chandra S VermaCold Spring Harbor Perspectives in Biology|May 14, 2010
p53-based cancer therapyDavid P Lane, Chit Fang Cheok, Sonia LainScientific Reports|April 1, 2016
Long range recognition and selection in IDPs: the interactions of the C-terminus of p53Srinivasaraghavan Kannan, David P Lane, Chandra S VermaThe Journal of Pathology|July 20, 2019
Intratumour heterogeneity of p53 expression; causes and consequencesYuezhen Xue, Boris San Luis, David P LaneCell Cycle (Georgetown, Tex.)|August 3, 2007
HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophyAnwesha Dey, Sheng-Hao Chao, David P LaneMolecular Cancer Research : MCR|November 21, 2007
Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combinationChit Fang Cheok, Anwesha Dey, David P LanePageof 30